* Individual results will vary. In clinical studies of 141 dogs, completing a 4-month weight-loss studty, 97.8% lost some weight by Day 112. Half of the dogs (50%) that completed the weight-loss phase had a body weight loss of 11% or more, an amount associated with health benefits. The range of weight loss resulted in a mean of 11.8% with a maximum of 29.5%; 1 dog lost no weight and 2 gained weight to a maximum of 1.8%.

Canine obesity is an important medical condition2,3 with serious health implications.4 And it's a growing problem. Today, as many as 25% to 40% of dogs are overweight or obese.3,5

For dogs, being overweight or obese has been associated with serious health implications, such as osteoarthritis,6-8 cardiac disease,9,10 respiratory conditions,11 insulin resistance,12,13 increased surgical and anesthetic risk,14 heat and exercise intolerance,15 and cruciate rupture.16,17

Obesity requires serious treatment. While exercise and diet remain important, they are not always enough. The need for a proven and dependable medication that can help veterinarians manage obesity safely and effectively has long been evident.

Today that solution is here... a medically appropriate approach to weight management called SLENTROL.

Steady, sustained weight loss over time

Zoetis has developed SLENTROL, the first FDA-approved weight-loss medication shown to be safe, effective, and dependable in helping manage canine obesity.

A clinically proven treatment, SLENTROL works primarily by reducing appetite and decreasing food intake. It is a once-daily, oral medication with a treatment plan specifically designed to respond to the individual needs of each dog.

Treatment with SLENTROL provides steady, sustained weight loss over time, during which owners can develop new and fundamentally better feeding behaviors and exercise regimens for their dogs.

Reliable weight reduction with SLENTROL occurs in a gradual and safe manner–the preferred, medically responsible way to lose weight.

Explore this site to learn how SLENTROL works, read helpful tips on discussing weight with dog owners, and much more.

NEXT: Clinical Obesity in Dogs

SLENTROL should not be used in cats, dogs receiving long-term corticosteroid therapy, or in dogs with liver disease. The most common side effect is vomiting. In addition, dogs may experience diarrhea, lethargy, or anorexia. The client should be made aware that if any of these signs persist for more than 2 days the dog should be re-evaluated. SLENTROL is not for use in humans under any circumstances.